Home COVID-19 Matters

COVID-19 Matters

Random
Important Facts about Omicron

Important Facts about Omicron

Patrick Iwelunmor - 0

Towards The Decolonisation of Vaccine Development and Distribution

Patrick Iwelunmor - 0

COVID-19 and The Future of The World’s Economy

Patrick Iwelunmor - 0
Katsina Records First Monkeypox Case, Awaiting 15 results, Says Commissioner

US Reports First Death Linked to Monkeypox

News Agency Report - 0

COVID-19: The Dynamics of a Third Wave

Patrick Iwelunmor - 0

COVID-19 Vaccine: 57 % Completely, 10% Partially Vaccinated, Says NPHCDA

Idara Inyang - 0

Group Seeks Protocols on Monkeypox, Epidemics Prevention

News Agency Report - 0
New booster COVID-19 vaccine candidate effective against Omicron subvariants, Moderna says

WHO Tells Europe to ‘Act Now’ as COVID-19 Cases Triple

News Agency Report - 0
China Detects New ‘Langya’ Virus from Shrews, Infects Dozens

China Detects New ‘Langya’ Virus from Shrews, Infects Dozens

Temitope Obayendo - 0
Combatting COVID-19 pandemic cost the world $11tn – Afreximbank

COVID-19 Variant: UK Stops Flight From South Africa, Five Other Countries

News Agency Report - 0

Bayelsa Launches Third Round of COVID-19 Vaccination

News Agency Report - 0
Vaccines Remain Accessible in Nigeria, Says NCDC DG

Vaccines Remain Accessible in Nigeria, Says NCDC DG

Modupeoluwa Adebisi - 0

COVID-19: Myths and Misconceptions Among Rural Dwellers

Patrick Iwelunmor - 0

Adelusi-Adeluyi, Usifoh, Others Task Pharmacists to Close Gaps in Vaccination

Adebayo Oladejo - 0
Long Covid symptoms affect one in eight –Study

Long Covid Symptoms Affect One in Eight –Study

News Agency Report - 0
Monkeypox: Avoid Contacts with Monkeys, Squirrels & Rodents, NCDC Warns

Edo State Confirms Eight Cases of Monkeypox

News Agency Report - 0
Pharmanews Limited is a health care publishing, training and consultancy firm, positioned to ensure consistent improvements in the quality of pharmaceutical and health care services through publishing and training.
Contact us: Info@pharmanewsonline.com

POPULAR POSTS

POPULAR CATEGORY

© © 2023 Pharmanews Limited. All rights reserved.